Based on data from the past 90 days ending January 10, 2026, Apellis Pharmaceuticals's three largest insider shareholders are TenPercentOwner Venture Investments Ltd Morningside (12.81Mn shares), Chief Scientific Officer Pascal Deschatelets (1.16Mn shares), Chief Executive Officer Cedric Francois (639.55K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Investments Ltd Morningside | 12,806,342 | 18 Nov, 2021 | |
| Pascal Deschatelets | Chief Scientific Officer | 1,160,496 | 22 May, 2025 |
| Cedric Francois | Chief Executive Officer | 639,551 | 18 Jul, 2025 |
| Alec Machiels | 396,939 | 05 Jan, 2026 | |
| A. Sinclair Dunlop | 191,709 | 05 Jan, 2026 | |
| Timothy Eugene Sullivan | Chief Financial Officer | 171,332 | 23 Oct, 2025 |
| David O. Watson | General Counsel | 154,754 | 09 Jan, 2026 |
| Kelley Boucher | Chief People Officer | 97,658 | 03 Sep, 2025 |
| Federico Grossi | Chief Medical Officer | 94,884 | 09 Jan, 2023 |
| Caroline Baumal | Chief Medical Officer | 91,206 | 06 Jan, 2026 |
| Adam J. Townsend | Chief Commercial Officer | 84,050 | 30 Jan, 2025 |
| Mark Jeffrey Delong | Chief Business & Strat Officer | 83,945 | 12 Feb, 2025 |
| Nur Nicholson | Chief Technical Officer | 83,664 | 30 Jan, 2025 |
| Karen Lewis | Chief People Officer | 70,251 | 30 Jan, 2025 |
| Lukas Scheibler | Chief Research Officer | 68,299 | 05 Dec, 2023 |
| Leslie Meltzer | Chief Research And Development | 61,804 | 02 Sep, 2025 |
| Jeffrey Eisele | Chief Development Officer | 55,312 | 30 Jan, 2025 |
| James George Chopas | Vp/Chief Accounting Officer | 53,468 | 16 Sep, 2025 |
| Paul R. Fonteyne | 30,666 | 05 Jan, 2026 | |
| Gerald Chan | 25,666 | 05 Jan, 2026 | |
| Stephanie Monaghan O'Brien | 25,666 | 05 Jan, 2026 | |
| Craig A Wheeler | 24,444 | 05 Jan, 2026 | |
| Victoria L. Brown | Program Team Lead | 23,556 | 24 Jan, 2023 |
| Keli Walbert | 17,051 | 05 Jan, 2026 | |
| Nicole D Perry | Vice President Accounting | 4,847 | 03 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | David O. Watson | Common Stock | A | 888 | $14.95 | 104,618 | D | M |
| 05 Jan, 2026 | Caroline Baumal | Common Stock | D | 3,020 | $25.53 | 91,206 | D | S |
| 01 Jan, 2026 | Craig A Wheeler | Common Stock | A | 7,961 | $0.00 | 24,444 | D | A |
| 01 Jan, 2026 | Alec Machiels | Common Stock | A | 7,961 | $0.00 | 384,989 | D | A |
| 01 Jan, 2026 | Gerald Chan | Common Stock | A | 7,961 | $0.00 | 25,666 | D | A |
| 01 Jan, 2026 | Stephanie Monaghan O'Brien | Common Stock | A | 7,961 | $0.00 | 25,666 | D | A |
| 01 Jan, 2026 | A. Sinclair Dunlop | Common Stock | A | 7,961 | $0.00 | 161,567 | D | A |
| 01 Jan, 2026 | Paul R. Fonteyne | Common Stock | A | 7,961 | $0.00 | 30,666 | D | A |
| 01 Jan, 2026 | Keli Walbert | Common Stock | A | 7,961 | $0.00 | 17,051 | D | A |
| 16 Dec, 2025 | David O. Watson | Common Stock | D | 5,000 | $24.49 | 103,730 | D | S |
| 17 Nov, 2025 | David O. Watson | Common Stock | D | 5,000 | $20.06 | 108,730 | D | S |
| 21 Oct, 2025 | Timothy Eugene Sullivan | - | - | 120,936 | D | |||
| 21 Oct, 2025 | Timothy Eugene Sullivan | Common Stock | D | 10,000 | $28.03 | 110,936 | D | S |
| 21 Oct, 2025 | Timothy Eugene Sullivan | Common Stock | A | 10,000 | $10.03 | 120,936 | D | M |
| 21 Oct, 2025 | Timothy Eugene Sullivan | - | - | 110,936 | D | |||
| 16 Oct, 2025 | David O. Watson | Common Stock | D | 5,000 | $25.22 | 113,730 | D | S |
| 30 Sep, 2025 | A. Sinclair Dunlop | Common Stock | D | 31,092 | $22.58 | 33,979 | I | S |
| 30 Sep, 2025 | A. Sinclair Dunlop | Common Stock | D | 3,837 | $0.00 | 30,142 | I | J |
| 19 Sep, 2025 | A. Sinclair Dunlop | - | - | 65,071 | I | |||
| 19 Sep, 2025 | A. Sinclair Dunlop | Common Stock | D | 3,837 | $0.00 | 65,071 | I | J |